Nymox Pharmaceutical Corp (NASDAQ:NYMX)

1.32
Delayed Data
As of 2:43pm ET
 -0.018 / -1.34%
Today’s Change
0.33
Today|||52-Week Range
5.75
+230.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues752.3K735.5K729.1K2.6M
 
 
 
 
 
Cost of Goods Sold48.2K45.4K23.0K37.5K
 
 
 
 
 
Depreciation And Amortization1.5K1.9K1.7K1.8K
 
 
 
 
 
 
Operating ExpensesGross Income702.5K688.2K704.4K2.5M
 
 
 
 
 
General Expenses1.6M1.4M1.4M915.6K
 
 
 
 
 
Research And Development1.1M897.5K737.3K557.5K
 
 
 
 
 
Total Operating Expenses1.6M1.5M1.4M954.9K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-860.7K-734.3K-710.9K1.6M
 
 
 
 
 
Extraordinary Credit0.000.00189.6K0.00
 
 
Interest Expense On Debt--0.0070.7K52.5K
 
 
 
Other Expenses-44.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-904.7K-725.0K-592.0K1.6M
 
 
 
 
 
Income Taxes-84.4K-36.8K-99.2K0.00
 
 
 
 
Net Income-820.3K-688.2K-492.8K1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.1M35.4M35.9M36.3M
 
 
 
 
 
Shares To Calculate EPS Diluted35.1M35.4M35.9M38.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.02$0.04
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.01$0.04
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account